ribavirin has been researched along with Deafness, Sudden in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galizio, C; Johnson, K; Sargent, LA; Ubogu, EE | 1 |
| Ha, CY; Ju, K; Jung, WT; Kim, TH; Lee, OJ; Min, HJ; Shin, MK | 1 |
| Adinolfi, LE; Barillari, M; Costa, G; Marrone, A; Zampino, R | 1 |
| Denk, DM; Ferenci, P; Formann, E; Gangl, A; Jessner, W; Munda-Steindl, P; Stauber, R; Zollner, G | 1 |
| Berkan, E; Jozefowicz-Korczynska, M; Piekarska, A; Wojcik, K | 1 |
| Elloumi, H; Gargouri, D; Ghorbel, A; Hadj, NB; Houissa, F; Kharrat, J; Romani, M | 1 |
1 trial(s) available for ribavirin and Deafness, Sudden
| Article | Year |
|---|---|
Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.
Topics: Adult; Amantadine; Audiometry; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing Loss, Sudden; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prognosis; Recombinant Proteins; Ribavirin; Risk Assessment; RNA, Viral; Sampling Studies; Severity of Illness Index | 2004 |
5 other study(ies) available for ribavirin and Deafness, Sudden
| Article | Year |
|---|---|
Interferon-alpha-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient.
Topics: Antiviral Agents; Drug Therapy, Combination; Hearing Loss, Sudden; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tinnitus; Vertigo | 2008 |
[A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Audiometry, Pure-Tone; Drug Therapy, Combination; Hearing Loss, Sudden; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prednisone; Recombinant Proteins; Ribavirin | 2009 |
Reversible sudden hearing loss in a chronic hepatitis C patient who achieved a sustained response to antiviral re-treatment.
Topics: Alanine Transaminase; Anemia; Antiviral Agents; Biomarkers; Drug Monitoring; Drug Substitution; Drug Therapy, Combination; Hearing Loss, Sudden; Hearing Loss, Unilateral; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2012 |
Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin.
Topics: Adult; Antiviral Agents; Audiometry, Pure-Tone; Disease Progression; Drug Therapy, Combination; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Turner Syndrome | 2007 |
Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment.
Topics: Antiviral Agents; Drug Therapy, Combination; Hearing Loss, Sudden; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |